Bianka Paquet-Bolduc
Overview
Explore the profile of Bianka Paquet-Bolduc including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carazo S, Denis G, Padet L, Deshaies P, Villeneuve J, Paquet-Bolduc B, et al.
Antimicrob Steward Healthc Epidemiol
. 2023 Nov;
3(1):e180.
PMID: 38028905
Objective: We described the evolution of SARS-CoV-2 source of infection in a cohort of healthcare workers (HCWs) of Quebec, Canada, during the first three pandemic waves. We also estimated their...
2.
Carazo S, Villeneuve J, Laliberte D, Longtin Y, Talbot D, Martin R, et al.
Infect Control Hosp Epidemiol
. 2022 Sep;
44(7):1121-1130.
PMID: 36082690
Objectives: In Québec, Canada, we evaluated the risk of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection associated with (1) the demographic and employment characteristics among healthcare workers (HCWs) and...
3.
Schweitzer L, Gervais P, Paquet-Bolduc B, Loo V, Longtin Y
Open Forum Infect Dis
. 2021 Jun;
8(6):ofab209.
PMID: 34113687
Cell cytotoxicity neutralization assay (CCNA) is considered to be a gold standard to diagnose infections. We performed CCNA on 77 consecutive admission screening rectal swabs from asymptomatic toxigenic carriers. Thirty-nine...
4.
Poirier D, Gervais P, Fuchs M, Roussy J, Paquet-Bolduc B, Trottier S, et al.
Clin Infect Dis
. 2019 Jul;
70(10):2103-2210.
PMID: 31290544
Background: Asymptomatic patients colonized with Clostridioides difficile are at risk of developing C. difficile infection (CDI), but the factors associated with disease onset are poorly understood. Our aims were to...
5.
Paquet-Bolduc B, Gervais P, Roussy J, Trottier S, Oughton M, Brukner I, et al.
Clin Infect Dis
. 2018 May;
67(11):1781-1783.
PMID: 29771298
During 4 Clostridium difficile infection outbreaks, unit-wide screening of 114 patients led to detection and isolation of 15 (13%) C. difficile asymptomatic carriers. Carriage prevalence varied between outbreaks, from 0%...
6.
Xiao Y, Paquet-Bolduc B, Garenc C, Gervais P, Trottier S, Roussy J, et al.
Clin Infect Dis
. 2017 Nov;
66(9):1377-1382.
PMID: 29149279
Background: The isolation of asymptomatic Clostridium difficile (CD) carriers may decrease the incidence of hospital-associated C. difficile infections (CDI), but its impact on isolation precaution needs is unknown. Methods: A...
7.
Longtin Y, Paquet-Bolduc B, Gilca R, Garenc C, Fortin E, Longtin J, et al.
JAMA Intern Med
. 2016 Apr;
176(6):796-804.
PMID: 27111806
Importance: Clostridium difficile infection (CDI) is a major cause of health care-associated infection worldwide, and new preventive strategies are urgently needed. Current control measures do not target asymptomatic carriers, despite...
8.
Longtin Y, Trottier S, Brochu G, Paquet-Bolduc B, Garenc C, Loungnarath V, et al.
Clin Infect Dis
. 2012 Sep;
56(1):67-73.
PMID: 23011147
Background: Most Clostridium difficile infection (CDI) surveillance programs neither specify the diagnostic method to be used nor stratify rates accordingly. We assessed the difference in healthcare-associated CDI (HA-CDI) incidence and...